Cas:109512-76-7 7-hydroxy-4-pyridin-3-ylchromen-2-one manufacturer & supplier

We serve Chemical Name:7-hydroxy-4-pyridin-3-ylchromen-2-one CAS:109512-76-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

7-hydroxy-4-pyridin-3-ylchromen-2-one

Chemical Name:7-hydroxy-4-pyridin-3-ylchromen-2-one
CAS.NO:109512-76-7
Synonyms:7-hydroxy-4-pyridin-3-yl-chromen-2-one
Molecular Formula:C14H9NO3
Molecular Weight:239.22600
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:63.33000
Exact Mass:239.05800
LogP:2.56060

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 7-hydroxy-4-pyridin-3-yl-chromen-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-hydroxy-4-pyridin-3-yl-chromen-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-hydroxy-4-pyridin-3-yl-chromen-2-one Use and application,7-hydroxy-4-pyridin-3-yl-chromen-2-one technical grade,usp/ep/jp grade.


Related News: “Alcami supported this product with supply constraints and successfully developed a capsule formulation for two dosage strengths,” she explains. “The formulations group performed studies at a micro-laboratory scale using a scientifically-based approach to identify a lead prototype. (Z)-3-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-3-morpholino-N-phenylacrylamide manufacturers This scheme has a total outlay of Rs. 6,940 crore for the entire period. The applications under four different target segments were invited on November 30, 2020. Of the 215 applications, 36 products across the 4 target segments were granted. (4-Chloro-phenyl)-[4-phenyl-5H-thiazol-(2E)-ylidene]-amine; hydrobromide suppliers Both were randomised, double-blinded, placebo-controlled trials in patients with moderate to severe autoantibody-positive SLE who were receiving standard therapy. 4-(2,4-dimethyl-phenyl)-valeric acid vendor & factory.